SCHEMBL7945708

SCHEMBL7945708

O=C(O)[C@H]1C[C@@H]2C[C@H](CP(=O)(O)O)CC[C@@H]2CN1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 1.00
KMT2A Q03164 2/20 1.00
KDM4E B2RXH2 1/20 1.00
GRIA1 P42261 4/20 0.61
GRIA2 P42262 4/20 0.61
GRIA3 P42263 4/20 0.61
GRIA4 P48058 4/20 0.61
GRIN2D O15399 3/20 0.61
GRIN3B O60391 3/20 0.61
GRIN1 Q05586 3/20 0.61
GRIN2A Q12879 3/20 0.61
GRIN2B Q13224 3/20 0.61
GRIN2C Q14957 3/20 0.61
GRIN3A Q8TCU5 3/20 0.61
ALDH1A1 P00352 1/20 0.61
CYP1A2 P05177 1/20 0.61
THRB P10828 1/20 0.61
ALOX15 P16050 1/20 0.61
CYP2C19 P33261 1/20 0.61
GRIK1 P39086 5/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13431268 1.00 MEN1 (1.00) MEN1KMT2AKDM4EGRIA1GRIA2
SCHEMBL195083 1.00 MEN1 (1.00) MEN1KMT2AKDM4EGRIA1GRIA2
SCHEMBL6021490 1.00 MEN1 (1.00) MEN1KMT2AKDM4EGRIA1GRIA2
SCHEMBL9410041 1.00 MEN1 (1.00) MEN1KMT2AKDM4EGRIA1GRIA2
SCHEMBL2763546 1.00 MEN1 (1.00) MEN1KMT2AKDM4EGRIA1GRIA2
SCHEMBL16668991 1.00 MEN1 (1.00) MEN1KMT2AKDM4EGRIA1GRIA2
SCHEMBL7055997 1.00 MEN1 (1.00) MEN1KMT2AKDM4EGRIA1GRIA2
SCHEMBL20241728 1.00 MEN1 (1.00) MEN1KMT2AKDM4EGRIA1GRIA2
Methanesulfonamide SCHEMBL8296539 0.91 MEN1 (0.83) MEN1KMT2AKDM4EGRIA1GRIA2
SCHEMBL13431280 0.89 KDM4E (0.80) MEN1KMT2AKDM4EGRIA1GRIA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150190411-A1 ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-07-09 US disclosed
US-20150190411-A1 ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-07-09 US disclosed
US-20100075926-A1 ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-03-25 US disclosed
WO-2010011318-A2 ACTIVATIQN OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2010-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075926-A1 ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL GRIK5, HDAC11, GRIK1 MEN1 3148/4885KMT2A 1179/4885KDM4E 826/4885
US-20150190411-A1 ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL GRIK5, HDAC11, GRIK1 MEN1 3160/4885KMT2A 1184/4885KDM4E 833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.